Intervention

Avapritinib

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions25

Lead sponsors shown1

Clinical trials

1 shown

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid TumorsNCT04771520 · 2021-01-20

Common conditions

Anatomic Stage IV Breast Cancer AJCC v81 Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v81 Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v81 Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v81 Locally Advanced Malignant Solid Neoplasm1 Locally Advanced Melanoma1 Locally Advanced Primary Malignant Central Nervous System Neoplasm1 Locally Advanced Sarcoma1 Metastatic Malignant Solid Neoplasm1 Metastatic Melanoma1 Metastatic Primary Malignant Central Nervous System Neoplasm1 Metastatic Sarcoma1 Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v81 Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v81 Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v81 Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v81 Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v81 Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v81 Prognostic Stage IIIC Breast Cancer AJCC v81 Prognostic Stage IV Breast Cancer AJCC v81 Stage IIIC Colorectal Cancer AJCC v81 Stage IIIC Lung Cancer AJCC v81 Stage IV Colorectal Cancer AJCC v81 Stage IV Lung Cancer AJCC v81 Stage IVA Colorectal Cancer AJCC v81

Leading sponsors

M.D. Anderson Cancer Center1

Trial status mix

RECRUITING1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.